Nonapnea sleep disorders in patients younger than 65 years are significantly associated with CKD: A nationwide population-based study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Lin, Hugo You Hsien ^a,b,c   Hung, Chi Chih ^a   Chang, Yu Han ^b   Lin, Ming Yen ^a   Yang, Ming Yu ^d   Liang, Shih Shin ^b   Liu, Wangta ^b   Chen, Hung Chun ^a,c   Hwang, Shang Jyh ^a,c,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GOUT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INSOMNIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONAPNEA SLEEP DISORDER; OBESITY; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SLEEP DISORDER; SUBURBAN AREA; TAIWAN; URBAN AREA; AGE; AGED; COMPLICATION; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SLEEP WAKE DISORDERS;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SLEEP WAKE DISORDERS; TAIWAN;

EID: 84948947433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140401     Document Type: Article

References (43)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72(3):247-59. doi: 10.1038/sj.ki.5002343 PMID: 17568785.
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. doi: 10.1001/jama.298.17.2038 PMID: 17986697.
3. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008; 371(9631):2173-82. doi: 10.1016/S0140-6736(08)60952-6 PMID: 18586172.
4. Turner JM, Bauer C, Abramowitz MK, Melamed ML, Hostetter TH. Treatment of chronic kidney disease. Kidney Int. 2012; 81(4):351-62. doi: 10.1038/ki.2011.380 PMID: 22166846.
5. Jalal DI, Chonchol M, Chen W, Targher G. Uric acid as a target of therapy in CKD. Am J Kidney Dis. 2013; 61(1):134-46. doi: 10.1053/j.ajkd.2012.07.021 PMID: 23058478; PubMed Central PMCID: PMC3525781.
6. Stenvinkel P, Zoccali C, Ikizler TA. Obesity in CKD - what should nephrologists know? J Am Soc Nephrol. 2013; 24(11):1727-36. doi: 10.1681/ASN.2013040330 PMID: 24115475; PubMed Central PMCID: PMC3810091.
7. Massy ZA, de Zeeuw D. LDL cholesterol in CKD - to treat or not to treat? Kidney Int. 2013; 84(3):451-6 doi: 10.1038/ki.2013.181 PMID: 23698234.
8. Shankar A, Sun L, Klein BE, Lee KE, Muntner P, Nieto FJ, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int. 2011; 80(11):1231-8. doi: 10.1038/ki.2011.283 PMID: 21866089; PubMed Central PMCID: PMC3260339.
9. Buysse DJ. Insomnia. JAMA. 2013; 309(7):706-16. doi: 10.1001/jama.2013.193 PMID: 23423416; PubMed Central PMCID: PMC3632369.
10. Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, et al. Association of sleep-related problems with CKD in the United States, 2005-2008. Am J Kidney Dis. 2011; 58(4):554-64. doi: 10.1053/j.ajkd. 2011.05.024 PMID: 21816524.
11. Sakaguchi Y, Shoji T, Kawabata H, Niihata K, Suzuki A, Kaneko T, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol. 2011; 6(5):995-1000. doi: 10.2215/CJN. 08670910 PMID: 21415314; PubMed Central PMCID: PMC3087795.
12. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. The New England journal of medicine. 2000; 342(19):1378-84. doi: 10.1056/NEJM200005113421901 PMID: 10805822.
13. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998; 98(11):1071-7. PMID: 9736593.
14. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002; 105(21):2462-4. PMID: 12034649.
15. Prabhakar NR. Sleep apneas: an oxidative stress? Am J Respir Crit Care Med. 2002; 165(7):859-60. doi: 10.1164/ajrccm.165.7.2202030c PMID: 11934709.
16. TM C. Taiwan's National Health Insurance system: high value for the dollar. In: Okma KG, Crivelli L, editors Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan.71-204.
17. Chung WS, Lin CL, Chen YF, Chiang JY, Sung FC, Chang YJ, et al. Sleep disorders and increased risk of subsequent acute coronary syndrome in individuals without sleep apnea: a nationwide populationbased cohort study. Sleep. 2013; 36(12):1963-8. doi: 10.5665/sleep.3240 PMID: 24293772; PubMed Central PMCID: PMC3825447.
18. Benz RL, Pressman MR, Hovick ET, Peterson DD. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis. 2000; 35(6):1052-60. PMID: 10845816.
19. Hanly P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial. 2004; 17 (2):109-14. doi: 10.1111/j.0894-0959.2004.17206.x PMID: 15043611.
20. Agarwal R, Light RP. Sleep and activity in chronic kidney disease: a longitudinal study. Clin J Am Soc Nephrol. 2011; 6(6):1258-65. doi: 10.2215/CJN.10581110 PMID: 21415310; PubMed Central PMCID: PMC3109920.
21. Iseki K, Tohyama K, Matsumoto T, Nakamura H. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertension research: official journal of the Japanese Society of Hypertension. 2008; 31(2):249-55. doi: 10.1291/hypres.31.249 PMID: 18360044.
22. Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007; 30(3):274-80. PMID: 17425223.
23. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study. Sleep. 1991; 14(5):392-8. PMID: 1759091.
24. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987; 91(4):540-6. PMID: 3829746.
25. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003; 14(7 Suppl 2):S131-8 PMID: 12819318.
26. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension. 1996; 27(6):1318-24. PMID: 8641742.
27. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on Creactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004; 43(4):678-83. doi: 10.1016/j.jacc.2003.07.050 PMID: 14975482.
28. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999; 354(9188):1435-9. doi: 10.1016/S0140-6736(99)01376-8 PMID: 10543671.
29. Knutson KL, Van Cauter E, Rathouz PJ, Yan LL, Hulley SB, Liu K, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Archives of internal medicine. 2009; 169(11):1055-61 doi: 10.1001/archinternmed.2009.119 PMID: 19506175; PubMed Central PMCID: PMC2944774.
30. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006; 47(5):833-9. doi: 10.1161/01.HYP.0000217362.34748.e0 PMID: 16585410.
31. Xu Q, Song Y, Hollenbeck A, Blair A, Schatzkin A, Chen H. Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes care. 2010; 33(1):78-83. doi: 10.2337/dc09-1143 PMID: 19825823; PubMed Central PMCID: PMC2797990.
32. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes care. 2010; 33(2):414-20. doi: 10.2337/dc09-1124 PMID: 19910503; PubMed Central PMCID: PMC2809295.
33. Roddy E, Muller S, Hayward R, Mallen CD. The association of gout with sleep disorders: a cross-sectional study in primary care. BMC musculoskeletal disorders. 2013; 14:119. doi: 10.1186/1471-2474-14-119 PMID: 23557073; PubMed Central PMCID: PMC3621781.
34. Roumelioti ME, Ranpuria R, Hall M, Hotchkiss JR, Chan CT, Unruh ML, et al. Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transplant. 2010; 25(11):3733-41. doi: 10.1093/ndt/gfq234 PMID: 20466675; PubMed Central PMCID: PMC2980993.
35. Agarwal R, Light RP. GFR, proteinuria and circadian blood pressure. Nephrol Dial Transplant. 2009; 24 (8):2400-6. doi: 10.1093/ndt/gfp074 PMID: 19251741.
36. Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int. 2004; 65(5):1568-76. doi: 10.1111/j.1523-1755.2004.00552.x PMID: 15086894.
37. Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, et al. Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. Journal of hypertension. 1994; 12(3):277-83 PMID: 8021481.
38. Charloux A, Gronfier C, Lonsdorfer-Wolf E, Piquard F, Brandenberger G. Aldosterone release during the sleep-wake cycle in humans. The American journal of physiology. 1999; 276(1 Pt 1):E43-9. PMID: 9886949.
39. Murck H, Uhr M, Ziegenbein M, Kunzel H, Held K, Antonijevic IA, et al. Renin-angiotensin-aldosterone system, HPA-axis and sleep-EEG changes in unmedicated patients with depression after total sleep deprivation. Pharmacopsychiatry. 2006; 39(1):23-9. doi: 10.1055/s-2006-931476 PMID: 16453251.
40. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004; 89 (5):2119-26. doi: 10.1210/jc.2003-031562 PMID: 15126529.
41. Sauvet F, Leftheriotis G, Gomez-Merino D, Langrume C, Drogou C, Van Beers P, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. Journal of applied physiology. 2010; 108 (1):68-75. doi: 10.1152/japplphysiol.00851.2009 PMID: 19910332.
42. Ohkuma T, Fujii H, Iwase M, Ogata-Kaizu S, Ide H, Kikuchi Y, et al. Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry. PLOS ONE. 2013; 8(11):e78968. doi: 10.1371/journal.pone.0078968 PMID: 24265736; PubMed Central PMCID: PMC3827127.
43. Huang ST, Lin CL, Yu TM, Yang TC, Kao CH. Nonapnea sleep disorders and incident chronic kidney disease: a population-based retrospective cohort study. Medicine. 2015; 94(4):e429. doi: 10.1097/MD. 0000000000000429 PMID: 25634175.